Team develops new way to grow blood vessels

August 17, 2018 by Jennifer Reiley, Texas A&M University
A photo of research conducted by Dr. Akhilesh Gaharwar and his team to develop a new platform to form blood vessels Credit: Texas A&M University

Formation of new blood vessels, a process also known as angiogenesis, is one of the major clinical challenges in wound healing and tissue implants. To address this issue, researchers from Texas A&M University have developed a clay-based platform to deliver therapeutic proteins to the body to assist with the formation of blood vessels.

The team is led by members of the Inspired Nanomaterials and Tissue Engineering Lab in the Department of Biomedical Engineering. They have developed technology that introduces a new type of two-dimensional clay, also known as nanosilicates, that delivers multiple specialized proteins called growth factors into the body to stimulate new . To allow time to form, the clay is designed to prolong the release through its high surface area and charged characteristics, according to assistant professor Dr. Akhilesh K. Gaharwar.

"Clay nanoparticles work like tiny weak magnets that hold the growth factors within the polymeric hydrogels and release very slowly," Gaharwar said. "Sustained and prolonged release of physiologically relevant doses of growth factors are important to avoid problems due to high doses, such as abrupt tissue formation."

Co-investigator Dr. Kayla Bayless from the Department of Molecular and Cellular Medicine in the Texas A&M Health Science Center said the clay also keeps the growth factors organized, preventing abnormal growth and moderating activity of surrounding cells.

Gaharwar said by establishing nanoparticles as a platform technology for delivering the , the research will have a significant impact on designing the next generation of bioactive scaffolds and implants.

The research was recently published in Advanced Biosystems.

Explore further: Researchers develop injectable bandage

More information: David W. Howell et al, 2D Nanosilicates Loaded with Proangiogenic Factors Stimulate Endothelial Sprouting, Advanced Biosystems (2018). DOI: 10.1002/adbi.201800092

Related Stories

Researchers develop injectable bandage

April 2, 2018
A penetrating injury from shrapnel is a serious obstacle in overcoming battlefield wounds that can ultimately lead to death.Given the high mortality rates due to hemorrhaging, there is an unmet need to quickly self-administer ...

Recommended for you

RNAi therapy mitigates preeclampsia symptoms

November 19, 2018
A collaboration of scientists from the University of Massachusetts Medical School, Beth Israel Deaconess Medical Center and Western Sydney University, have shown that an innovative new type of therapy using small interfering ...

Skeletal imitation reveals how bones grow atom-by-atom

November 19, 2018
Researchers from Chalmers University of Technology, Sweden, have discovered how our bones grow at an atomic level, showing how an unstructured mass orders itself into a perfectly arranged bone structure. The discovery offers ...

Signal peptides' novel role in glutamate receptor trafficking and neural synaptic activity

November 19, 2018
Glutamate is the major excitatory neurotransmitter in the brain, and the postsynaptic expression level of glutamate receptors is a critical factor in determining the efficiency of information transmission and the activity ...

New insights into how an ordinary stem cell becomes a powerful immune agent

November 19, 2018
How do individual developing cells choose and commit to their "identity"—to become, for example, an immune cell, or a muscle cell, or a neuron?

A molecule for fighting muscular paralysis

November 19, 2018
Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva (UNIGE), ...

Mouse model aids study of immunomodulation

November 19, 2018
Because mice do not respond to immunomodulatory drugs (IMiDs), preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice. This has led to an inability to accurately ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.